Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,998 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Laminin-221 Enhances Therapeutic Effects of Human-Induced Pluripotent Stem Cell-Derived 3-Dimensional Engineered Cardiac Tissue Transplantation in a Rat Ischemic Cardiomyopathy Model.
Samura T, Miyagawa S, Kawamura T, Fukushima S, Yokoyama JY, Takeda M, Harada A, Ohashi F, Sato-Nishiuchi R, Toyofuku T, Toda K, Sekiguchi K, Sawa Y. Samura T, et al. Among authors: takeda m. J Am Heart Assoc. 2020 Aug 18;9(16):e015841. doi: 10.1161/JAHA.119.015841. Epub 2020 Aug 12. J Am Heart Assoc. 2020. PMID: 32783519 Free PMC article.
Pivotal Role of Non-cardiomyocytes in Electromechanical and Therapeutic Potential of Induced Pluripotent Stem Cell-Derived Engineered Cardiac Tissue.
Iseoka H, Miyagawa S, Fukushima S, Saito A, Masuda S, Yajima S, Ito E, Sougawa N, Takeda M, Harada A, Lee JK, Sawa Y. Iseoka H, et al. Among authors: takeda m. Tissue Eng Part A. 2018 Feb;24(3-4):287-300. doi: 10.1089/ten.TEA.2016.0535. Epub 2017 Jun 13. Tissue Eng Part A. 2018. PMID: 28498040 Free PMC article.
Development of In Vitro Drug-Induced Cardiotoxicity Assay by Using Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells.
Takeda M, Miyagawa S, Fukushima S, Saito A, Ito E, Harada A, Matsuura R, Iseoka H, Sougawa N, Mochizuki-Oda N, Matsusaki M, Akashi M, Sawa Y. Takeda M, et al. Tissue Eng Part C Methods. 2018 Jan;24(1):56-67. doi: 10.1089/ten.TEC.2017.0247. Epub 2017 Nov 17. Tissue Eng Part C Methods. 2018. PMID: 28967302 Free PMC article.
Phenotypic recapitulation and correction of desmoglein-2-deficient cardiomyopathy using human-induced pluripotent stem cell-derived cardiomyocytes.
Shiba M, Higo S, Kondo T, Li J, Liu L, Ikeda Y, Kohama Y, Kameda S, Tabata T, Inoue H, Nakamura S, Takeda M, Ito E, Takashima S, Miyagawa S, Sawa Y, Hikoso S, Sakata Y. Shiba M, et al. Among authors: takeda m. Hum Mol Genet. 2021 Jul 9;30(15):1384-1397. doi: 10.1093/hmg/ddab127. Hum Mol Genet. 2021. PMID: 33949662 Free PMC article.
Clinical Outcomes of Autologous Stem Cell-Patch Implantation for Patients With Heart Failure With Nonischemic Dilated Cardiomyopathy.
Domae K, Miyagawa S, Yoshikawa Y, Fukushima S, Hata H, Saito S, Kainuma S, Kashiyama N, Iseoka H, Ito E, Harada A, Takeda M, Sakata Y, Toda K, Pak K, Yamada T, Sawa Y. Domae K, et al. Among authors: takeda m. J Am Heart Assoc. 2021 Jul 6;10(13):e008649. doi: 10.1161/JAHA.117.008649. Epub 2021 Jul 2. J Am Heart Assoc. 2021. PMID: 34212772 Free PMC article. Clinical Trial.
3,998 results